Evidence-based research
Explore the evidence behind GLP-1 treatment, safety and access. If you’re comparing prices, our cash-price guide explains which charges to look for in the monthly plan comparison.
When the evidence turns into choosing a provider, the reviews of RxSpan MD, Shed and HealthRX each list prices for both semaglutide and tirzepatide, and each program says it serves all 50 states.
44 articles
The molecules
Semaglutide vs Tirzepatide: Which Molecule Fits You
The two GLP-1 molecules head to head — trial weight-loss data, the single-vs-dual mechanism, and how to decide which one to ask your provider for.
6 sourcesRead guideThe molecules
Injections vs Oral or Sublingual GLP-1: What to Know
Compare approved GLP-1 injections and tablets, and learn why evidence for an approved tablet does not apply to compounded lozenges or drops.
5 sourcesRead guideThe molecules
Ozempic vs Wegovy: Same Drug, Two Different FDA Approvals
Ozempic and Wegovy are both semaglutide. What differs is the FDA-approved indication, the maximum dose, and a cardiovascular-risk claim only one carries.
4 sourcesRead guideThe molecules
Wegovy vs Zepbound: The Head-to-Head Trial and Approved Uses
Wegovy is semaglutide, Zepbound is tirzepatide. The pivotal trials, a real head-to-head study, and what each drug's own FDA label adds the other doesn't.
6 sourcesRead guideThe molecules
Mounjaro vs Zepbound: Same Drug, Two FDA Approvals
Mounjaro and Zepbound are both tirzepatide, from Eli Lilly. What differs is the FDA-approved use — and, since Dec. 2024, one has an approval the other doesn't.
4 sourcesRead guideThe molecules
Rybelsus vs Ozempic: Oral vs Injectable Semaglutide
Rybelsus and Ozempic are both semaglutide, from Novo Nordisk, both approved only for type 2 diabetes — not weight loss. Here's what the route actually changes.
3 sourcesRead guideThe molecules
Wegovy vs Saxenda: The Randomized Trial That Compared Them Directly
Saxenda (liraglutide) came first; Wegovy (semaglutide) came later. A real randomized trial — STEP 8 — compared them directly. Here's what it found.
4 sourcesRead guideCompounded vs brand-name
Compounded vs Brand-Name GLP-1: How to Read the Trade-Off
Brand-name Wegovy and Zepbound are FDA-approved; compounded GLP-1 is not. Here is what that difference actually means for cost, access and safety.
7 sourcesRead guideCompounded vs brand-name
Is Compounded GLP-1 Legit and Safe?
Compounded GLP-1 is legal but not FDA-approved. What 503A and 503B mean after the FDA's 2025–2026 changes, why LegitScript matters, and how to vet a compounder.
6 sourcesRead guideChoosing a provider
How to Choose a GLP-1 Provider That Fits You
A six-point checklist for picking a GLP-1 telehealth provider — price, state access, molecule, speed, support and licensing — matched to your situation.
2 sourcesRead guideChoosing a provider
How to Tell If a GLP-1 Telehealth Provider Is Legitimate
Red flags and a step-by-step verification checklist — state license lookups, pharmacy accreditation, instant-approval traps and pricing scams — for GLP-1 sites.
13 sourcesRead guideChoosing a provider
Best GLP-1 Provider by Need: Budget, Oral, Fast Start, Nationwide
No provider wins on every axis. Our best-for-X picks — cheapest, oral-capable, fastest onboarding and widest state reach — with the trade-offs.
2 sourcesRead guideSide effects & safety
GLP-1 Side Effects: What the Trials and FDA Labels Actually Show
Real numbers from the pivotal trials and FDA labels — how common nausea and diarrhea are, the boxed warnings, and when a side effect means call your provider.
5 sourcesRead guideSide effects & safety
GLP-1 and Muscle Loss: What the Body-Composition Data Shows
GLP-1 weight loss isn't all fat. What DXA-scan substudies measured, why the lean-mass share varies so much between studies, and what it does and doesn't mean.
4 sourcesRead guideSide effects & safety
GLP-1 and Hair Loss: What Causes It, and When It Stops
Hair thinning is not on the Wegovy or Zepbound label, but it is widely reported and increasingly studied — the mechanism, timing and who is affected.
2 sourcesRead guideSide effects & safety
GLP-1 and Alcohol: What Happens When You Drink on Semaglutide or Tirzepatide
What Wegovy and Zepbound labels say about alcohol, what randomized semaglutide trials found in alcohol use disorder, and where evidence is still limited.
5 sourcesRead guideSide effects & safety
"Ozempic Face": What Causes It, and What the Evidence Actually Says
Facial hollowing after rapid GLP-1 weight loss is real and now studied — the peer-reviewed evidence on why it happens, and what it doesn't prove yet.
2 sourcesRead guideSide effects & safety
GLP-1 Drugs and Depression: What the FDA and the Studies Found
The FDA requested removal of the suicide warning from three GLP-1 labels. What the agency found, what a Nordic cohort showed, and what remains uncertain.
4 sourcesRead guideSide effects & safety
GLP-1 Drugs Before Surgery: What the Aspiration-Risk Evidence Shows
GLP-1 drugs delay gastric emptying, raising aspiration risk under anesthesia. The actual gastric-ultrasound study data, and what it means for a procedure.
2 sourcesRead guideDosing & technique
GLP-1 Dosage and Titration Schedules: Semaglutide and Tirzepatide
The FDA-approved dose-escalation steps for Wegovy and Zepbound, why the climb is slow by design, and what happens if you miss a week.
2 sourcesRead guideDosing & technique
How to Inject GLP-1 Medications: Sites, Rotation and Timing
Where the FDA-approved instructions say to inject Wegovy or Zepbound, how to rotate sites correctly, and the timing rules for a weekly dose.
2 sourcesRead guideDosing & technique
GLP-1 Microdosing: What It Is, and What the Evidence Says
Microdosing GLP-1 means going below the FDA-approved starting dose, usually via compounded product. No randomized trial has tested it — what that gap means.
3 sourcesRead guideBeyond weight loss
GLP-1, the Heart and the Kidneys: The SELECT and FLOW Trials
Semaglutide's two newest FDA indications aren't about weight loss at all — they're for reducing heart-attack, stroke and kidney-disease risk directly.
4 sourcesRead guideBeyond weight loss
GLP-1 Weight Regain After Stopping: What the Withdrawal Trial Shows
What actually happened to STEP 1 participants a year after they stopped semaglutide — the real numbers, not the anecdote version.
1 sourceRead guideBeyond weight loss
Zepbound and Sleep Apnea: What the SURMOUNT-OSA Trial Showed
In December 2024, Zepbound became the first drug ever FDA-approved for obstructive sleep apnea. The SURMOUNT-OSA trial numbers behind that approval.
2 sourcesRead guideBeyond weight loss
GLP-1 Drugs for PCOS: What the Trials Actually Show
No GLP-1 drug is FDA-approved for PCOS. What the randomized trials that exist found on weight, hormones, and reproductive outcomes — and their real limits.
2 sourcesRead guideWhat it costs, and who pays
GLP-1 Cost Without Insurance: The Cash Prices
What Wegovy, Zepbound, Ozempic, Mounjaro and Foundayo cost cash from their makers, what compounded runs on our ranking, and what a monthly figure hides.
8 sourcesRead guideWhat it costs, and who pays
Compounded Semaglutide Cost: What Rows Really Say
What compounded semaglutide costs per month across 545 tracked providers, why the spread runs from $79 to $449, and where the 503A rules stand in August 2026.
6 sourcesRead guideWhat it costs, and who pays
Compounded Tirzepatide Cost: The Real Monthly
What compounded tirzepatide costs per month across 545 tracked providers, what the step across from semaglutide really adds, and where the 503A rules stand now.
6 sourcesRead guideWhat it costs, and who pays
Foundayo Cost: What the GLP-1 Pill Actually Runs
Foundayo (orforglipron) approval facts, label doses, and Lilly's published self-pay ladder — plus how the pill compares to Rybelsus and the weekly injections.
8 sourcesRead guideWhat it costs, and who pays
Medicare GLP-1 Coverage: What Part D Pays Now
Why Part D excludes weight-loss drugs, what the $50 Medicare GLP-1 Bridge covers, who qualifies, and which indications your own plan already pays for.
8 sourcesRead guideThe pharmacies behind the vial
Empower Pharmacy: What It Is and Who It Supplies
Empower runs a 503A pharmacy and a 503B outsourcing facility in Houston. What each may legally do, what FDA's records show, and how to check it yourself.
9 sourcesRead guideThe pharmacies behind the vial
Hallandale Pharmacy: What It Is and Who Uses It
Hallandale is a 503A compounding pharmacy in Fort Lauderdale that fills for prescribers, not the public. What that means, and the six companies naming it.
5 sourcesRead guideThe pharmacies behind the vial
Red Rock Pharmacy: What It Is and Who Uses It
A Utah 503A compounding pharmacy publishing a license number for 49 states and DC — and the pharmacy named by more companies here than any other.
5 sourcesRead guideThe pharmacies behind the vial
Olympia Pharmacy: What It Is and Who Uses It
Olympia runs a 503B outsourcing facility and a 503A pharmacy in Orlando. What each may legally do, what FDA's register records, and who names it here.
6 sourcesRead guideSingle-provider investigations
The Edit Review: $209 Semaglutide, $309 Tirzepatide
The Edit publishes a semaglutide and tirzepatide ladder whose prepay maths checks out exactly, plus a full Spanish site. What we verified in August 2026.
3 sourcesRead guideSingle-provider investigations
Pepti Review: $99 Semaglutide, and an Open Question
Pepti advertises $99 semaglutide flat at every dose. Its own production data carries a $299-$449 per-dose ladder. We could not break the tie — here is why.
3 sourcesRead guideSingle-provider investigations
Trellis Vitality Review: $150 Semaglutide, and a Gap
Trellis publishes a real 1/3/6-month GLP-1 table at $150 semaglutide and $199 tirzepatide. Everything else on the site is a starting-at number with no ladder.
3 sourcesRead guideSingle-provider investigations
Auren Rx Review: $199 Semaglutide, $299 Tirzepatide
Auren Rx publishes a subscribe rung and an explicit no-commitment rung on every SKU, plus a named microdose program. It never publishes the states it serves.
2 sourcesRead guideSingle-provider investigations
Vyvron Review: Billed Every 4 Weeks, Not Monthly
Vyvron advertises $199/mo semaglutide but bills every four weeks — thirteen charges a year. Its tirzepatide has no monthly rung; the entry is $790 prepaid.
2 sourcesRead guideSingle-provider investigations
Rehydra+ Review: A 6-Month Non-Cancelable Contract
Rehydra+ advertises GLP-1 from $119 a month. Every membership is a six-month non-cancelable contract, so the real minimum purchase is $714 to $2,514.
3 sourcesRead guideSingle-provider investigations
Lighter You Review: The $99 That Buys Nothing
Lighter You advertises 'start for just $99'. No program on the site costs $99; the cheapest is $145, and the only route to a real price is behind a login.
2 sourcesRead guideHow treatment plays out over time
Does GLP-1 Weight Loss Plateau? What the Physiology Shows
Weight loss on Wegovy or Zepbound levels off, and that's not the drug failing. What a 2024 modeling study found about why, versus diet and surgery.
3 sourcesRead guideHow treatment plays out over time
How Long GLP-1 Drugs Stay in Your System
Semaglutide and tirzepatide clear over weeks, not hours. The half-life figures from each FDA label, and what they mean for surgery and pregnancy planning.
4 sourcesRead guide